Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075091

« Back to Dashboard
NDA 075091 describes CARBIDOPA AND LEVODOPA, which is a drug marketed by Mayne Pharma, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, and Sun Pharma Global, and is included in twenty-three NDAs. It is available from twenty-six suppliers. Additional details are available on the CARBIDOPA AND LEVODOPA profile page.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

Summary for NDA: 075091

carbidopa; levodopa
Therapeutic Class:Antiparkinson Agents

Pharmacology for NDA: 075091

Mechanism of ActionDOPA Decarboxylase Inhibitors

Suppliers and Packaging for NDA: 075091

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL 075091 ANDA Mylan Pharmaceuticals Inc. 0378-0088 0378-0088-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-0088-01)
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL 075091 ANDA Mylan Pharmaceuticals Inc. 0378-0094 0378-0094-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-0094-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength50MG;200MG
Approval Date:Sep 30, 1999TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength25MG;100MG
Approval Date:Apr 21, 2000TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.